Chise 🧬🧫🦠💉, Discover and Read the Best of Twitter Threads by @sailorrooscout

Chise 🧬🧫🦠💉

A recent study shows Oxford/ AstraZeneca’s vaccine gives powerful protection and generates robust long-term immune system responses that may last a lifetime! As well as generating virus-busting antibodies, the vaccine

Immunological memory wins! A recent study shows immunity in convalescent individuals will be VERY long lasting and that convalescent individuals who received an mRNA vaccine produced antibodies and memory B-cells

I can’t express this strongly enough: even if later than planned, please be sure to get your second dose. Do not skip it because you are worried about side effects.

Time to clear up some confusion on vaccine efficacy and what the numbers actually mean. Let’s take Pfizer’s clinical trials for an example. One common misunderstanding is that 95% efficacy

Let’s discuss a couple of things.Firstly, vaccines DO NOT “promote mutations.” This is very dangerous and misleading. The only way mutation occurs is when a virus replicates. Vaccination means no

Cell-mediated immunity wins! A new study highlights the robust nature and kinetics of T-cell priming by SARS-CoV-2 mRNA vaccines. Why does this matter? Long-term antiviral immunity that is likely to

Immunological memory consists of antibodies, memory B-cells, memory CD8+ T-cells, and memory CD4+ T-cells. These responses are what give us enduring protection even against newly emerging SARS-CoV-2 variants. Immunological memory

Let’s talk. Breakthrough infections (infections in vaccinated individuals) are to be expected. Why? The vaccines are not 100%. Never have been. Otherwise, our vaccine trials would all have reported 100%

Vaccines work. An outbreak in a Kentucky nursing home involving a COVID variant with E484K in a vulnerable vaccinated population showed very effective (86.5%) protection against symptomatic illness. This is

Let’s talk about B.1.617. It is unlikely it will be able to evade vaccine-induced immunity. Why?•Vaccines are polyclonal (Abs)•Mutations compared to VOCs•CD8+ T-cells covering 52 epitopes across the spike protein•CD4+

Please be aware that out of 6.8M+ doses of the J&J vaccine that have been administered in the U.S., 6 cases of a rare & severe type of blood clot

Let’s settle this since this message seems to be very convoluted. It’s unlikely. There is a difference between a carrier and a transmitter. Vaccinated individuals can get infected and carry